Clinical Trial Update: Parental Decision-Making for Children With Relapsed Neuroblastoma

View source ↗

Summary

Clinical trial update from Dana-Farber Cancer Institute examining parental decision-making for children with relapsed neuroblastoma; the study (NCT02282735) is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Relapsed Neuroblastoma | Status: ACTIVE_NOT_RECRUITING